GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PeopleBio Co Ltd (XKRX:304840) » Definitions » Additional Paid-In Capital

PeopleBio Co (XKRX:304840) Additional Paid-In Capital : ₩76,754 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PeopleBio Co Additional Paid-In Capital?


PeopleBio Co's quarterly additional paid-in capital increased from Sep. 2023 (₩57,417 Mil) to Dec. 2023 (₩76,754 Mil) but then stayed the same from Dec. 2023 (₩76,754 Mil) to Mar. 2024 (₩76,754 Mil).

PeopleBio Co's annual additional paid-in capital increased from Dec. 2021 (₩46,626 Mil) to Dec. 2022 (₩49,432 Mil) and increased from Dec. 2022 (₩49,432 Mil) to Dec. 2023 (₩76,754 Mil).


PeopleBio Co Additional Paid-In Capital Historical Data

The historical data trend for PeopleBio Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeopleBio Co Additional Paid-In Capital Chart

PeopleBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 25,909.33 36,761.01 46,626.20 49,432.04 76,753.64

PeopleBio Co Quarterly Data
Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52,267.09 57,417.29 57,417.29 76,753.64 76,753.64

PeopleBio Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

PeopleBio Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PeopleBio Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


PeopleBio Co (XKRX:304840) Business Description

Traded in Other Exchanges
N/A
Address
242 Pangyo-ro, 6th Floor, PDC C-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
PeopleBio Co Ltd is a biotechnology company. The company is engaged in the business of developing diagnostic products for neurodegenerative diseases. The company's technology, Multimer Detection System (MDS), helps in detecting protein misfolding diseases like Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob's disease.

PeopleBio Co (XKRX:304840) Headlines

No Headlines